Error in the dosage of Methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
- PMID: 32024649
- DOI: 10.1136/annrheumdis-2020-217041
Error in the dosage of Methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Keywords: methotrexate; systemic vasculitis; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Error in the dosage of methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis' by Scheicht.Ann Rheum Dis. 2022 Jun;81(6):e90. doi: 10.1136/annrheumdis-2020-217063. Epub 2022 Feb 15. Ann Rheum Dis. 2022. PMID: 35168945 No abstract available.
Comment on
-
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.Ann Rheum Dis. 2016 Sep;75(9):1583-94. doi: 10.1136/annrheumdis-2016-209133. Epub 2016 Jun 23. Ann Rheum Dis. 2016. PMID: 27338776
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
